Inernally derived candidates, in-licensed candidates, development and commercialization

Science
with intent

Science with intent

Inernally derived candidates, in-licensed candidates, development and commercialization

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options.

Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.